Bradley L Campbell Amicus Therapeutics, Inc. (FOLD) insider trading activity

Bradley L Campbell is President and CEO of AMICUS THERAPEUTICS, INC.. Currently has a direct ownership of 1.14 Million shares of FOLD, which is worth approximately $9.59 Million. The most recent transaction as insider was on Oct 02, 2023, when has been sold 11,700 shares (Common Stock) at a price of $2.94 per share, resulting in proceeds of $34,398. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.14M

4.95% 3M change

28.27% 12M change

Total Value Held $9.59 Million

Bradley L Campbell Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 02 2023	BUY Exercise of conversion of derivative security	$34,398 $2.94 p/Share	11,700 Added 1.43%	803,861 Common Stock
Sep 01 2023	SELL Open market or private sale	$234,666 $12.97 p/Share	18,093 Reduced 2.23%	792,161 Common Stock
Sep 01 2023	BUY Exercise of conversion of derivative security	$34,398 $2.94 p/Share	11,700 Added 1.42%	810,254 Common Stock
Aug 01 2023	SELL Open market or private sale	$267,800 $13.39 p/Share	20,000 Reduced 2.44%	798,554 Common Stock
Aug 01 2023	BUY Exercise of conversion of derivative security	$34,398 $2.94 p/Share	11,700 Added 1.41%	818,554 Common Stock
Jul 13 2023	SELL Open market or private sale	$85,068 $12.51 p/Share	6,800 Reduced 0.84%	806,854 Common Stock
Jul 12 2023	SELL Open market or private sale	$18,765 $12.51 p/Share	1,500 Reduced 0.18%	813,654 Common Stock
Jul 03 2023	SELL Open market or private sale	$144,027 $12.31 p/Share	11,700 Reduced 1.42%	815,154 Common Stock
Jul 03 2023	BUY Exercise of conversion of derivative security	$34,398 $2.94 p/Share	11,700 Added 1.4%	826,854 Common Stock
Jun 06 2023	SELL Open market or private sale	$103,750 $12.5 p/Share	8,300 Reduced 1.01%	815,154 Common Stock
Jun 01 2023	SELL Open market or private sale	$132,912 $11.36 p/Share	11,700 Reduced 1.4%	823,454 Common Stock
Jun 01 2023	BUY Exercise of conversion of derivative security	$31,590 $2.7 p/Share	11,700 Added 1.38%	835,154 Common Stock
May 01 2023	SELL Open market or private sale	$138,060 $11.8 p/Share	11,700 Reduced 1.4%	823,454 Common Stock
May 01 2023	BUY Exercise of conversion of derivative security	$28,665 $2.45 p/Share	11,700 Added 1.38%	835,154 Common Stock
Apr 03 2023	SELL Open market or private sale	$131,157 $11.21 p/Share	11,700 Reduced 1.4%	823,454 Common Stock
Apr 03 2023	BUY Exercise of conversion of derivative security	$28,665 $2.45 p/Share	11,700 Added 1.38%	835,154 Common Stock
Mar 15 2023	SELL Payment of exercise price or tax liability	$152,876 $11.43 p/Share	13,375 Reduced 1.6%	823,454 Common Stock
Mar 01 2023	SELL Open market or private sale	$268,000 $13.4 p/Share	20,000 Reduced 2.33%	836,829 Common Stock
Mar 01 2023	BUY Exercise of conversion of derivative security	$28,665 $2.45 p/Share	11,700 Added 1.35%	856,829 Common Stock
Feb 01 2023	SELL Open market or private sale	$259,600 $12.98 p/Share	20,000 Reduced 2.31%	845,129 Common Stock
Feb 01 2023	BUY Exercise of conversion of derivative security	$28,665 $2.45 p/Share	11,700 Added 1.33%	865,129 Common Stock
Jan 11 2023	SELL Payment of exercise price or tax liability	$602,766 $12.02 p/Share	50,147 Reduced 5.55%	853,429 Common Stock
Jan 11 2023	BUY Grant, award, or other acquisition	-	98,040 Added 9.79%	903,576 Common Stock
Jan 09 2023	SELL Open market or private sale	$133,731 $11.43 p/Share	11,700 Reduced 1.43%	805,536 Common Stock
Jan 09 2023	BUY Exercise of conversion of derivative security	$28,665 $2.45 p/Share	11,700 Added 1.41%	817,236 Common Stock

BLC

Bradley L Campbell

President and CEO

Philadelphia, PA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells FOLD shares.

Notify only if

Value

Insider Trading

Get notified when an Amicus Therapeutics, Inc. insider buys or sells FOLD shares.

Notify only if

Operation

Value

Type

News

Receive news related to AMICUS THERAPEUTICS, INC.

Track Activities on FOLD

Account